HealthQuill Anthos Therapeutics
Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion to expand its cardiovascular pipeline.
Uncategorized

Switzerland’s Novartis to buy US-based Anthos for $3.1 billion

Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion.

Read More